Archangels - Making The Future


Archangel Informal Investment is Scotland's leading Business Angel Syndicate. Originally formed in 1992 and based in Edinburgh, the syndicate now comprises around 100 investor members and is investing c. £10m per year in early stage Scottish companies, including leverage from partners the largest being the Scottish Enterprise Co-Investment Fund.


We invest equity only, with no preferential terms, and provide significant business experience and networking opportunities to our portfolio companies.  We seek to invest in companies with high growth potential and global application and are prepared to become involved at all stages from proof of concept through growth capital in a wide variety of business sectors.  To find out more about our investment criteria and our decision making process please visit the Investment section.


We are always keen to attract new investor members and welcome the opportunity to meet with potential members to discuss our approach to investment.  We are an unregulated activity in terms of the FSA and therefore rely on certification of members as either High Net Worth Individuals or Sophisticated Investors as defined by the FSMA 2000.  Unless otherwise stated, all investment opportunities are carried out under the Enterprise Investment Scheme (EIS) rules and therefore attract tax benefits.  Please visit our Investors section to find out more about membership.

Our office is based in Central Edinburgh and provides resources for reviewing all investment opportunities and monitoring the performance of portfolio companies.  We are the largest partner of the Scottish Co-Investment Fund  which provides matching equity funding of up to 50% (£1m max) on any qualifying investment if required.


There are currently around 26 companies in our portfolio covering a wide spectrum of business activities.  Visit ourPortfolio section to find out more about the companies in which we are currently invested and follow the links to the websites of those companies for further information.

Latest News

Alpiq acquires Flexitricity Limited, a British market leader in demand response

22 Apr 2014
Lausanne (Switzerland) - Alpiq has acquired the British company Flexitricity. With this acquisition, Alpiq can support its strategy implementation by gaining access to specialised know-how and new markets in the area of decentralised energy management. Flexitricity is Great Britain’s leader in the management of networked services.

Calcivis® Caries Activity Imaging System Granted CE Mark

21 Apr 2014
Edinburgh, 12 February 2014 - Calcivis, a medical devices company focused on revolutionising the management of tooth decay, today announces that its Calcivis® Caries Activity Imaging System has been granted a CE Mark in Europe. A CE Mark is required before a medical device can be marketed in the EU and a number of other countries and signifies that the manufacturer meets the requirements of European legislation.

Bloxx Awarded International Patents

27 Mar 2014
Bloxx Awarded International Patents for its Dynamic Real-Time Web Page Categorisation Software

Touch Bionics sales reach £12.3 million in 2013

20 Jan 2014
20 January 2014 – Touch Bionics, a provider of world-leading prosthetic technologies, today announced that preliminary results indicate the company achieved revenue growth of 23% in 2013 to reach £12.3m in total sales.

PowerPhotonic Signs Partnership Deal in Israel

25 Oct 2013
World leader in precision laser micro-optics expands presence in new markets.